Press release
Chemotherapy-Induced Nausea and Vomiting (CINV) Market Research Explores Growth Within A $4.56 Billion Opportunity
Chemotherapy-Induced Nausea and Vomiting (CINV) Market
Projected Size and Growth Trajectory of the Chemotherapy-Induced Nausea and Vomiting Market
The global market for chemotherapy-induced nausea and vomiting is anticipated to reach $4.57 billion by 2030, expanding at a compound annual growth rate (CAGR) of 8.0%. This upward trend is largely fueled by growing demand for next-generation antiemetic medications, an increased focus on personalized antiemetic treatments, the broadening availability of outpatient chemotherapy services, and a stronger commitment to adhering to treatment protocols. Additionally, innovations in sustained-release drug formulations are contributing to this expansion. Key market trends expected through the forecast period include wider adoption of combination antiemetic therapies, increased use of long-acting CINV drugs, a shift toward patient-centric treatment models, the spread of preventive management strategies, and a heightened focus on improving patients' quality of life.
The chemotherapy-induced nausea and vomiting (cinv) market size has grown strongly in recent years. It will grow from $3.13 billion in 2025 to $3.35 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to increasing use of highly emetogenic chemotherapy, rising awareness of treatment side effects, availability of advanced antiemetic drugs, expansion of oncology treatment programs, improved clinical guidelines for cinv management.
Download a free sample of the chemotherapy-induced nausea and vomiting (cinv) market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13031&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Factors Fueling Growth in the Chemotherapy-Induced Nausea and Vomiting Market
Rising demand for advanced antiemetic therapies is a critical driver for market expansion. Patients and healthcare providers alike are seeking more effective options to manage nausea and vomiting associated with chemotherapy, prompting pharmaceutical companies to develop innovative treatments.
Furthermore, the growing emphasis on personalized medicine is playing a significant role. Tailoring antiemetic therapy to individual patient profiles helps improve treatment adherence and outcomes, which in turn supports market growth as healthcare systems prioritize patient-specific care plans.
Key Players Shaping the Chemotherapy-Induced Nausea and Vomiting Market
The CINV market includes several prominent companies driving innovation and product availability. Leading names include Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, AstraZeneca plc, GlaxoSmithKline plc, Baxter International Inc., Teva Pharmaceuticals Industries Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Ono Pharmaceutical Co. Ltd., Dr. Reddy's Laboratories Ltd., Kyowa Kirin Inc., Amneal Pharmaceuticals Inc., Mundipharma International Limited, Insys Therapeutics Inc., Lupin Limited, Helsinn Holding S.A., Heron Therapeutics Inc., Camurus AB, Cadila Pharmaceuticals Limited, Acacia Pharma Ltd., and Soligenix Inc.
In a notable collaboration, Helsinn Healthcare SA partnered with Immedica Pharma in January 2023 to commercialize cancer supportive care products across key European markets. This alliance aims to broaden patient access to established oncology supportive therapies, strengthen Helsinn's commercial presence in the region, and expand Immedica's portfolio with treatments addressing critical unmet needs in cancer care. Immedica AB is recognized for specializing in rare disease and specialty care pharmaceuticals.
View the full chemotherapy-induced nausea and vomiting (cinv) market report:
https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-nausea-and-vomiting-cinv-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Emerging Innovations and Trends in the CINV Market
Leading companies continue to focus on innovative product development to stay competitive. One such innovation is the introduction of fixed intravenous antiemetics, which provide a standardized dose administered via IV to prevent or treat nausea and vomiting related to chemotherapy or surgery.
For example, in January 2023, Glenmark Pharmaceuticals Limited launched AKYNZEO I.V. in India, the country's first fixed intravenous antiemetic combination targeting both acute and delayed nausea and vomiting phases. This product blends netupitant and palonosetron in a single dose, offering enhanced convenience, improved patient response rates, and a better quality of life for cancer patients. Clinical evidence indicates it is especially effective for those undergoing highly emetogenic chemotherapy.
Breakdown of the Chemotherapy-Induced Nausea and Vomiting Market Segments
The CINV market is categorized into various segments for detailed analysis:
1) Form: Injectables, Oral, Transdermal Patches
2) Drug Class: 5-HT3 Receptor Antagonists, Neurokinin-1 Receptor Antagonists, Corticosteroids, Cannabinoids, and other drug categories
3) Emetogenic Risk: Highly Emetogenic Chemotherapy (HEC), Moderately Emetogenic Chemotherapy (MEC), Low Emetogenic Chemotherapy (LEC)
4) Distribution Channels: CINV Hospitals, Cancer Research Institutes, Retail Pharmacies, Online Pharmacies, and Drug Stores
5) Application Areas: Gynecology, Urology, Gastrointestinal Surgery, and others
Subcategories include:
- Injectables: Intravenous (IV) Solutions, Intramuscular (IM) Injections
- Oral: Tablets, Capsules, Liquid formulations
- Transdermal Patches: Fentanyl Patches, Scopolamine Patches
This detailed segmentation allows for a comprehensive understanding of market dynamics and opportunities across different product types, treatment settings, and patient groups.
Expanded capabilities in our 2026 market reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chemotherapy-Induced Nausea and Vomiting (CINV) Market Research Explores Growth Within A $4.56 Billion Opportunity here
News-ID: 4606111 • Views: …
More Releases from The Business Research Company
Chronic Pain Market Outlook Highlights Strategic Opportunities Across The Indust …
The chronic pain market is on track for significant expansion in the coming years, driven by advances in treatment options and evolving healthcare delivery models. As demand grows for more personalized and effective pain management strategies, this sector is expected to witness considerable development through 2030. Let's explore the market's projected growth, key players, emerging trends, and important segments shaping its future.
Chronic Pain Market Size and Forecast Through 2030 …
Chronic Lower Back Pain Market Study Explores Industry Growth Toward $10.05 Bill …
Understanding the chronic lower back pain market reveals promising growth prospects driven by technological innovations and evolving treatment approaches. This sector is witnessing significant advancements aimed at addressing the complex needs of patients suffering from persistent back pain, with new therapies and personalized care strategies shaping its future landscape.
Projected Value and Expansion Rates in the Chronic Lower Back Pain Market
The chronic lower back pain market is set to…
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Research Reveals …
The chronic inflammatory demyelinating polyneuropathy (CIDP) market is poised for significant expansion in the coming years, driven by advancements in treatment and growing patient awareness. As the medical community continues to innovate, the market outlook suggests promising opportunities for enhanced therapies and improved patient care.
Anticipated Market Growth and Size of the CIDP Market
The CIDP market is projected to reach a value of $3.32 billion by 2030, growing at…
Chronic Cough Market Demonstrates Long-Term Growth Potential At 9.9% CAGR
The chronic cough market is positioned for significant expansion over the coming years, driven by advancements in treatment approaches and growing healthcare investments. Understanding the factors shaping this market, the key players involved, and emerging trends offers valuable insight into its future trajectory. Below is a detailed overview of the chronic cough market's size, leading companies, driving trends, and segmentation.
Projected Growth Outlook for the Chronic Cough Market Through 2030 …
More Releases for Chemotherapy
Chemotherapy Devices Market - Innovation for Life: Chemotherapy Devices Driving …
Newark, New Castle, USA: The "Chemotherapy Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Chemotherapy Devices Market: https://www.growthplusreports.com/report/chemotherapy-devices-market/8623
This latest report researches the industry structure, sales, revenue,…
Chemotherapy Devices Market 2022 Will Boom With Advanced Chemotherapy Technologi …
New Research Study ""Chemotherapy Devices Market 2022 analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges and Investment Opportunities), Size, Share and Outlook"" has been added to Coherent Market insight
The most recent Global Chemotherapy Devices Market report includes a high-level overview of the industry as well as in-depth analysis of key areas. The overview presented highlights the definition of products and services, as well as their associated applications, at the…
Cancer, chemotherapy and its treatment
Chemotherapy is one of the most commonly used cancer therapies. It employs the use of certain medications to destroy cancer cells or prevent them from spreading to other parts of the body. Chemotherapy may be prescribed alone or in combination with surgery or radiation therapy. Along with chemotherapy, you may also take newer types of cancer-fighting medications.
Chemotherapy can be taken as pills or as injections. You may visit a clinic…
Chemotherapy induced Nausea and Vomiting (CINV) TreatmentS Market Driven by Risi …
According to WHO cancer is one of the most leading causes for death with around 8 million deaths and 14 million new patients in 2012. Chemotherapy, which is received by approximately four million cancer patients each year, is among the most commonly used treatment to fight cancer. However, this mode of treatment has many side effects, an estimate of around 70% - 80% of the patients receiving chemotherapy treatment experience…
Nano Chemotherapy Market Nano Chemotherapy Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Nano Chemotherapeutics Mediations andndash; Solicitation to Nanomedicine
1.1 Overview
1.2 Nano Chemotherapeutics with Pharmaceutical Potential
Significance of Nano Chemotherapeutics to overcome the Chemotherapy Limitations
2.1 Limitations of Conventional Chemotherapy
2.2 Nanotechnology in Cancer Targeting
2.2.1 Active Targeting
2.2.2 Passive Targeting
2.2.3 pH Dependent Drug Delivery Through Nanoparticles
Role…
Nano Chemotherapy Is Emerging As An Important Anti-Cancer Modality By Supplement …
“Global Nano Chemotherapy Market and Clinical Trials Outlook 2022” report highlights the current development in the in the field of nano chemotherapy. Report gives comprehensive insight on various clinical and non-clinical parameters associated with the expansion of global nano chemotherapeutics market. The clinical and pricing insight on chemotherapeutics nanoformulations of approved drugs helps to understand the current market scenario of the nano chemotherapeutics.
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Download Report:…
